Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2010

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

10 mg ilaprazole

Two 5-mg ilaprazole tablets (Livzon Pharm Group Inc., China) together with one placebo tablet of ilaprazole and one placebo tablet of esomeprazole in a package being taken orally each morning on an empty stomach for 8 weeks

DRUG

15 mg ilaprazole

Three 5-mg ilaprazole tablets (Livzon Pharm Group Inc., China) together with one placebo tablet of esomeprazole in a package being taken orally each morning on an empty stomach for 8 weeks

DRUG

40 mg esomeprazole

One 40-mg esomeprazole tablet (AstraZeneca, Nexium) together with three 5-mg placebo tablets of ilaprazole in a package being taken orally each morning on an empty stomach for 8 weeks

All Listed Sponsors
lead

Livzon Pharmaceutical Group Inc.

INDUSTRY